Outrunning pancreatic cancer: the potential impact of exercise on treatment responses
We spoke to Emma Kurz, a PhD earning her MD Degree at NYU Grossman School of Medicine (NY, USA), about her research investigating the link between aerobic exercise and anti-tumor immune activity in models of pancreatic cancer. According to Johns Hopkins Medicine, the 5-year survival rate of pancreatic cancer is 5-10%, partly because it is difficult to detect and is often only caught after it has metastasized, leaving patients with few treatment options. Cancer can weaken the immune system, so a combination of immunotherapy with another treatment, such as chemotherapy, is proving to be a promising way of fighting stubborn...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
